# H&A HOLLAND · 66-41 · NETHERLANDS — FDA import alert red lists: firms subject to detention without physical examination

For H&A HOLLAND · 66-41 · NETHERLANDS, import alert is 66-41; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; country is NETHERLANDS; product is MAZI TAHIN (SESAME PASTE) | MAZI TAHIN (SESAME PASTE) | MAZI TAHIN (SESAME PASTE); product code is 23 R - - 02 Sesame Seed (Edible Seed Paste) | 37 K - - 21 Sesame Paste | 66 V - - 99 Miscellaneous Patent Medicines, Etc; date published is 01/05/2022; address is Stephensonstraat 10 R , Zoetermeer, Zuid-Holland NETHERLANDS, verified against its source on 2026-09-16.

- **Firm:** H&A HOLLAND _(verified: appears in the quote below)_
- **Import alert:** 66-41
- **Import alert name:** Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
- **Country:** NETHERLANDS _(verified: appears in the quote below)_
- **Address:** Stephensonstraat 10 R , Zoetermeer, Zuid-Holland NETHERLANDS _(verified: appears in the quote below)_
- **Date published:** 01/05/2022 _(verified: appears in the quote below)_
- **Product code:** 23 R - - 02 Sesame Seed (Edible Seed Paste) | 37 K - - 21 Sesame Paste | 66 V - - 99 Miscellaneous Patent Medicines, Etc. _(verified: each item appears in the quote below)_
- **Product:** MAZI TAHIN (SESAME PASTE) | MAZI TAHIN (SESAME PASTE) | MAZI TAHIN (SESAME PASTE) _(verified: each item appears in the quote below)_
- **FDA notes:** The product appears to be an unapproved new drug as the product’s labeling includes statements such as (not an all-inclusive list): ‘[the ingredient Tahin] reduces the chance of high blood pressure, anemia and cancer . . . and lowers bad cholesterol.’. | The product appears to be an unapproved new drug as the product’s labeling includes statements such as (not an all-inclusive list): ‘[the ingredient Tahin] reduces the chance of high blood pressure, anemia and cancer . . . and lowers bad cholesterol.’. | The product appears to be an unapproved new drug as the product’s labeling includes statements such as (not an all-inclusive list): ‘[the ingredient Tahin] reduces the chance of high blood pressure, anemia and cancer . . . and lowers bad cholesterol.’. _(verified: each item appears in the quote below)_

## What the source says

> H&A HOLLAND Date Published : 01/05/2022 Stephensonstraat 10 R , Zoetermeer, Zuid-Holland NETHERLANDS 23 R - - 02 Sesame Seed (Edible Seed Paste) Date Published: 01/05/2022 Desc: MAZI TAHIN (SESAME PASTE) Notes: The product appears to be an unapproved new drug as the product’s labeling includes statements such as (not an all-inclusive list): ‘[the ingredient Tahin] reduces the chance of high blood pressure, anemia and cancer . . . and lowers bad cholesterol.’. 37 K - - 21 Sesame Paste Date Published: 01/05/2022 Desc: MAZI TAHIN (SESAME PASTE) Notes: The product appears to be an unapproved new drug as the product’s labeling includes statements such as (not an all-inclusive list): ‘[the ingredient Tahin] reduces the chance of high blood pressure, anemia and cancer . . . and lowers bad cholesterol.’. 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 01/05/2022 Desc: MAZI TAHIN (SESAME PASTE) Notes: The product appears to be an unapproved new drug as the product’s labeling includes statements such as (not an all-inclusive list): ‘[the ingredient Tahin] reduces the chance of high blood pressure, anemia and cancer . . . and lowers bad cholesterol.’.

## Source

- https://www.accessdata.fda.gov/cms_ia/importalert_190.html

Last verified: 2026-09-16. Review by: 2026-11-15.
Part of [FDA import alert red lists: firms subject to detention without physical examination](https://referencesource.org/fda-import-alert-red-list/).